Indegene Limited (NSE:INDGN)
India · Delayed Price · Currency is INR 610.00
-3.35 (-0.55%)
Nov 6, 2026, 3:29 PM IST
Indegene Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 41,309 | 35,105 | 28,393 | 25,896 | 23,061 | 16,646 |
Revenue Growth | 35.84% | 23.64% | 9.64% | 12.29% | 38.54% | 69.76% |
Gross Profit Gross Profit Growth | 40,531 | 34,327 | 27,769 | 25,308 | 22,649 | 16,322 |
Operating Income Operating Income Growth | 5,155 | 4,970 | 4,541 | 4,347 | 3,363 | 2,535 |
Net Income Net Income Growth | 4,111 | 4,011 | 4,067 | 3,367 | 2,661 | 1,648 |
Earnings Per Share EPS Growth | 17.01 | 16.62 | 17.02 | 15.07 | 11.97 | 7.46 |
EPS Growth | -8.02% | -2.35% | 12.94% | 25.90% | 60.46% | 41.50% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Enterprise Medical Solutions Enterprise Medical Solutions Growth | 10,413 | 9,298 | 8,025 | 6,008 | 5,602 | 4,316 |
Others Others Growth | 1,510 | 1,202 | 1,020 | 1,410 | 1,063 | 754.78 |
Enterprise Commercial Solutions (Incl. Omnichannel Activation) Enterprise Commercial Solutions (Incl. Omnichannel Activation) Growth | - | 24,605 | 19,348 | - | - | - |
Total Total Growth | 41,309 | 35,105 | 28,393 | 25,896 | 23,061 | 16,646 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 12,560 | 14,814 | 16,643 | 9,875 | 6,960 | 6,261 |
Total Debt Total Debt Growth | 1,573 | 1,583 | 1,016 | 4,896 | 5,025 | 657.52 |
Net Cash (Debt) Net Cash Growth | 10,987 | 13,231 | 15,627 | 4,979 | 1,935 | 5,604 |
Net Cash Growth | -4.14% | -15.33% | 213.86% | 157.31% | -65.47% | 583.62% |
Net Cash Per Share Net Cash Per Share Growth | 45.46 | 54.82 | 65.41 | 22.28 | 8.71 | 25.39 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 4,347 | 6,508 | 4,419 | 5,077 | 1,302 | 2,970 |
Capital Expenditures CapEx Growth | -537 | -443 | -300 | -107 | -188 | -247.09 |
Free Cash Flow Free Cash Flow Growth | 3,810 | 6,065 | 4,119 | 4,970 | 1,114 | 2,723 |
Free Cash Flow Growth | -18.64% | 47.24% | -17.12% | 346.14% | -59.09% | 79.86% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 98.12% | 97.78% | 97.80% | 97.73% | 98.21% | 98.05% |
Operating Margin | 12.48% | 14.16% | 15.99% | 16.79% | 14.58% | 15.23% |
Pretax Margin | 13.07% | 14.96% | 18.99% | 17.71% | 15.74% | 13.61% |
Profit Margin | 9.95% | 11.43% | 14.32% | 13.00% | 11.54% | 9.90% |
FCF Margin | 9.22% | 17.28% | 14.51% | 19.19% | 4.83% | 16.36% |
Fiscal Year | Current | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Nov '26 Nov 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 2.250 | 2.250 | 2.000 |
Dividend Per Share Growth | 0% | 12.50% | - |
Dividend Yield | 0.37% | 0.52% | 0.35% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 35.86 | 26.01 | 34.03 | - | - | - |
Forward PE | 24.76 | 21.02 | 29.50 | - | - | - |
P/FCF Ratio | 38.57 | 17.20 | 33.60 | - | - | - |
PS Ratio | 3.56 | 2.97 | 4.88 | - | - | - |